Atlas Trials

Molecular Profiling After Neoadjuvant Chemotherapy for Triple-negative Breast Cancer

Clinical trial NCT04362462 · UNKNOWN

Trial details

NCT number
NCT04362462
Sponsor
Texas Tech University Health Sciences Center, El Paso
Status
UNKNOWN
Study type
OBSERVATIONAL
Triple-negative Breast Cancer
Start date
2019-03-05
Primary completion
2022-12-31
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.